[Automatic translation follows] Polymeris, Competitiveness cluster for rubbers, plastics and composites POLYMERIS is the only competitiveness cluster dedicated to rubbers, plastics and composites. It is the result of combining the skills, 15 years of experience and resources of Elastopôle and Plastipolis. Polymeris works to serve all manufacturers to bring out new R&D projects, encourage and promote innovation and focuses its roadmap around 2 major strategic axes: the circular economy and the industry of the future. A benchmark in terms of innovation, we work in France and internationally to promote a dynamic and innovative industry, supporting the emergence and sustainability of …

Sectors: French Cluster Industry Public business cluster

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

[Automatic translation follows] PariSanté Campus, here digital health grows! PariSanté Campus aims to create a coherent and synergistic group of public and private operators, with the ambition of structuring a research and innovation sector in digital health with global influence. This group will be set up on the site of the former Val-de-Grâce military training hospital, and to create a network of partnerships in the Paris region, nationally and internationally. The group will be financed by unprecedented investments from the recovery plan, and will aim to be a major vector for the creation of medical-scientific, but also economic, value. Based …